Kraig Biocraft Laboratories, Inc. is focused on the development of high performance technical fibers and polymers using spiders and silkworms. While the production of a “super fiber” is the company’s primary focus at this time, it is also considering the production of other unique proteins using transgenic silkworms. It is thought there is a large viable market for such proteins in the pharmaceutical and biotechnology industries.

Kraig Biocraft is involved in research related to utilizing spider genes for insertion into silkworms to create a transgenic variety of silkworms. These silkworms will be capable of spinning a new “super fiber” that is similar to natural spider silk, which is one of the strongest and most resilient fibers known. Natural spider silk is five times as strong as steel of the same diameter.

Kraig Biocraft has acquired the exclusive US rights, in their field of

...

Kraig Biocraft Laboratories, Inc. is focused on the development of high performance technical fibers and polymers using spiders and silkworms. While the production of a “super fiber” is the company’s primary focus at this time, it is also considering the production of other unique proteins using transgenic silkworms. It is thought there is a large viable market for such proteins in the pharmaceutical and biotechnology industries.

Kraig Biocraft is involved in research related to utilizing spider genes for insertion into silkworms to create a transgenic variety of silkworms. These silkworms will be capable of spinning a new “super fiber” that is similar to natural spider silk, which is one of the strongest and most resilient fibers known. Natural spider silk is five times as strong as steel of the same diameter.

Kraig Biocraft has acquired the exclusive US rights, in their field of use, to

...

Kraig Biocraft Laboratories Inc. is a company focused on the development of high performance technical fibers and polymers utilizing spider genes which are inserted into silkworms. The company aims to create a transgenic variety of silkworms capable of spinning a new “super fiber” that is similar to natural spider silk, one of the strongest and most resilient fibers known.

While the production of a “super fiber” is Kraig Biocraft’s primary focus, the company is also considering the production of other unique proteins utilizing transgenic silkworms as a protein expression platform. It is thought that there is a large, viable market for these unique proteins in the pharmaceutical and biotechnology industries, among others.

Kraig Biocraft has acquired the exclusive rights, in their field of use, to use the genetic sequences patented by the University of Wyoming and the genetic engineering technology developed by the University of Notre Dame.

...

Today we are featuring top-performing "health" equity mutual funds that primarily invest in common stocks of health care and related companies.

Investors can find such funds by checking out the entire list of the Zacks #1 Rank Health Equity Funds list.

3 Healthy Picks

Alger Health Sciences A (AHSAX) seeks long-term capital appreciation. It primarily invests in equity securities of companies of any market capitalization that are engaged in the health sciences sector. It can leverage, that is, borrow money to buy additional securities.

The value of the portfolio's shares is more volatile than other mutual funds that do not concentrate their investments in one sector. AHSAX offers dividends and capital gains annually. Unit holders have to make a minimum initial investment of $1000 to enter this Zacks#1 Rank ("Strong Buy") fund.

Its top holdings include Optimer Pharmaceuticals Inc. (

...

Omnicare (OCR) is staging a nice rebound after seeing to recent lows. Analysts are upbeat on the company, boosting full-year forecasts from $2.41 per share to $2.56 over the past 3 months. < ?DART(15);?>

Company Description

Omnicare, Inc. provides pharmaceutical care for the elderly. Omnicare serves residents in long-term care facilities and other chronic care settings comprising beds in fourteen states, the District of Columbia and Canada.

Omnicare is the largest U.S. provider of professional pharmacy, related consulting and data management services for skilled nursing, assisted living and other institutional healthcare providers as well as for hospice patients in homecare and other settings.

Omnicare's pharmacy services also include distribution and patient assistance services for specialty pharmaceuticals. Omnicare offers clinical research services for the pharmaceutical and biotechnology industries in thirty countries worldwide

Robust Results

The company recently announced fourth-quarter adjusted earnings of 66 cents per share, exceeding the consensus estimate by 5%

...

Omnicare, Inc. (...